chitosan has been researched along with Cardiac Remodeling, Ventricular in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, T; Hou, M; Liu, Y; Wang, Y; Zhang, Y | 1 |
| Ai, S; Blažek, P; Brittenham, GM; Chen, D; Chen, YP; Cortez, LM; Daude, N; Deisenhofer, I; Dwivedi, G; Eskandari-Sedighi, G; Fegan, PG; Friedrich, L; Fu, B; Gotoh, M; Grebmer, C; Green, G; Habibi, A; Hadadi, M; Hattori, R; Hectors, SJ; Hegde, AR; Iwata, H; Jabłońska, J; Jafari, R; Kantenwein, V; Karami, S; Kato, M; Kawanishi, H; Kluska, M; Koehne de González, AK; Kolb, C; Kulkarni, VI; Lan, NSR; Lan, X; Lennerz, C; Li, C; Li, Q; Li, X; Li, Y; Lim, MA; Lin, CH; Lin, XJ; Liu, R; Manne, ASN; Murase, Y; Mutalik, S; O'Connor, M; Pranata, R; Prince, MR; Rankin, JM; Rao, RR; Raut, SY; Reents, T; Sassa, N; Schaarschmidt, C; Seko, S; Shi, W; Shmeit, K; Sim, V; Spincemaille, P; Sun, G; Sun, J; Tsuzuki, T; Varmira, K; von Olshausen, G; Walker, MJ; Wang, Y; Wang, Z; Waterhouse, GIN; Weigand, S; Westaway, D; Xu, XM; Yang, J; Yeap, BB; Yi, X; Zhang, J; Zhang, M; Zhang, Y; Zheng, J; Zhou, M | 1 |
| Cao, F; Chen, J; Deng, H; Fan, L; Han, D; Li, C; Li, X; Luo, Z; Ma, S; Tao, B; Wang, Q; Wang, Y; Zhan, Y | 1 |
| Deng, B; Ding, X; Ge, J; Jia, J; Lu, S; Qian, J; Shen, L; Shen, Y; Wu, Y | 1 |
| Henning, RJ; Jimenez, E; Khan, A | 1 |
| Duan, C; Li, Y; Lin, Q; Liu, Z; Ma, Y; Wang, C; Wang, H; Wang, Y; Zhang, X; Zhang, Y; Zhou, J | 1 |
| Binsalamah, ZM; Khan, AA; Paul, A; Prakash, S; Shum-Tim, D | 1 |
7 other study(ies) available for chitosan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
The Anti-inflammatory Effect of Chitosan Oligosaccharide on Heart Failure in Mice.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oligosaccharides; Ventricular Remodeling | 2022 |
Topics: Acute Coronary Syndrome; Adolescent; Adsorption; Adult; Aged; Animals; Aspergillus; Aspergillus oryzae; Benzhydryl Compounds; Biocatalysis; Biological Availability; Biomarkers; Biomass; Brain; Brain Injuries, Traumatic; Cadmium; Calorimetry, Differential Scanning; Carbon; Carcinoma, Transitional Cell; Catalysis; Cell Death; Cells, Immobilized; Child; Child, Preschool; China; Chitosan; Creatine Kinase, MB Form; Cyclodextrins; Defibrillators, Implantable; Dendritic Spines; Diabetes Mellitus, Type 2; Diastole; Directed Molecular Evolution; Disease Models, Animal; Disease Progression; Down-Regulation; Electric Countershock; Electrolytes; Electrophoresis, Polyacrylamide Gel; Endopeptidase K; Environmental Monitoring; Esterification; Esters; Feasibility Studies; Female; Fruit; Gene Library; Glial Fibrillary Acidic Protein; Glucosides; Hippocampus; Humans; Hydrogen-Ion Concentration; Hydrolysis; Infant; Infant, Newborn; Inflammation; Ions; Kinetics; Lipase; Liver Cirrhosis; Logistic Models; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malus; Maze Learning; Melatonin; Mercury; Mice; Mice, Inbred C57BL; Middle Aged; Mining; Molecular Docking Simulation; Molecular Weight; Molybdenum; Motor Cortex; Mutagenesis, Site-Directed; Mutation; Neoplasm Recurrence, Local; Nephrectomy; Nephroureterectomy; Neurons; Oxidative Stress; Patient Discharge; Proof of Concept Study; Propionates; Prospective Studies; Protein Engineering; Protein Structure, Quaternary; Protons; PrPC Proteins; PrPSc Proteins; Rats; Rats, Wistar; Recovery of Function; Registries; Retrospective Studies; Rivers; ROC Curve; Scrapie; Sodium-Glucose Transporter 2 Inhibitors; Solubility; Solvents; Spatial Memory; Stereoisomerism; Synapses; Temperature; Time Factors; Treatment Outcome; Troponin T; Urinary Bladder Neoplasms; Urinary Tract; Ventricular Function, Left; Ventricular Remodeling; Water; Water Pollutants, Chemical; Water Purification; X-Ray Diffraction; Young Adult; Zebrafish | 2021 |
Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
Topics: Adipose Tissue; Animals; Apoptosis; Biomarkers; Cell Survival; Cellulose; Chitosan; Disease Models, Animal; Fibroins; Heart Function Tests; Hemodynamics; Implants, Experimental; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Transgenic; Myocardial Infarction; Nanofibers; Neovascularization, Physiologic; Organ Size; Rats, Sprague-Dawley; Static Electricity; Ventricular Remodeling; Water | 2018 |
Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction.
Topics: Alginates; Animals; Apoptosis; Biocompatible Materials; Cell Proliferation; Chitosan; Disease Models, Animal; Fibrosis; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Inflammation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Regeneration; Regenerative Medicine; Shear Strength; Spectroscopy, Fourier Transform Infrared; Temperature; Tissue Engineering; Ventricular Remodeling | 2015 |
Chitosan hydrogels significantly limit left ventricular infarction and remodeling and preserve myocardial contractility.
Topics: Animals; Chitosan; Drug Evaluation, Preclinical; Hydrogels; Injections; Male; Myocardial Contraction; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Rats, Sprague-Dawley; Ventricular Remodeling | 2016 |
Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel.
Topics: Animals; Chitosan; Collagen; Disease Models, Animal; Drug Therapy, Combination; Female; Fibroblast Growth Factor 2; Heart; Hemostatics; Hydrogels; Myocardial Infarction; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Temperature; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model.
Topics: Alginates; Analysis of Variance; Animals; Chitosan; Cytokines; Electrocardiography; Female; Glucuronic Acid; Hexuronic Acids; Immunohistochemistry; Myocardial Infarction; Nanoparticles; Neovascularization, Physiologic; Particle Size; Pharmaceutical Vehicles; Placenta Growth Factor; Pregnancy Proteins; Rats; Rats, Inbred Lew; Stroke Volume; Ventricular Remodeling | 2011 |